Fortrea Holdings (FTRE) Accumulated Expenses (2022 - 2026)

Fortrea Holdings (FTRE) reported Accumulated Expenses of $357.3 million for Q1 2026, up 2.91% on a YoY basis from $347.2 million in Q1 2025, and down 9.73% quarter-over-quarter from $395.8 million in Q4 2025.

Fortrea Holdings (FTRE) Accumulated Expenses (2022 - 2026) Analysis & Trends

Fortrea Holdings has reported Accumulated Expenses for 5 years, with the latest figure at $357.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Accumulated Expenses rose 2.91% year-over-year to $357.3 million; the trailing twelve-month figure through Mar 2026 stood at $357.3 million (up 2.91% YoY), and the FY2025 full-year result was $395.8 million, up 7.03% from the prior year.
  • Accumulated Expenses for Q1 2026 stood at $357.3 million, down from $395.8 million in the prior quarter.
  • The five-year high for Accumulated Expenses was $395.8 million in Q4 2025, with the low at $322.7 million in Q4 2022.
  • Historically, Accumulated Expenses has averaged $349.7 million across 5 years, with a median of $343.3 million in 2024.
  • Annual changes were most pronounced in 2024 — Accumulated Expenses slipped 3.78% — and 2025, when it gained 14.39%.
  • Fortrea Holdings' Accumulated Expenses stood at $322.7 million in 2022, then advanced by 3.97% to $335.5 million in 2023, then increased by 10.22% to $369.8 million in 2024, then climbed by 7.03% to $395.8 million in 2025, then dropped by 9.73% to $357.3 million in 2026.
  • The last three Accumulated Expenses figures came in at $357.3 million (Q1 2026), $395.8 million (Q4 2025), and $369.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Fortrea Holdings 1.43 Bn 1.28 Bn 123.60 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 357.30 Mn
Dec 31, 2025 395.80 Mn
Sep 30, 2025 369.60 Mn
Jun 30, 2025 380.80 Mn
Mar 31, 2025 347.20 Mn
Dec 31, 2024 369.80 Mn
Sep 30, 2024 323.10 Mn
Jun 30, 2024 343.30 Mn
Mar 31, 2024 328.70 Mn
Dec 31, 2023 335.50 Mn
Sep 30, 2023 335.80 Mn
Jun 30, 2023 336.20 Mn
Dec 31, 2022 322.70 Mn